(2962 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergyAbstract Food allergy can result in considerable morbidity, impairment of quality of life...
-
EAACI guidelines on allergen immunotherapy: Hymenoptera venom allergyAbstract Hymenoptera venom allergy is a potentially life-threatening allergic reaction fo...
-
EAACI guidelines on allergen immunotherapy: Prevention of allergyAbstract Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT...
-
EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitisAbstract Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes a...
-
EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthmaAbstract Allergen immunotherapy (AIT) has been in use for the treatment of allergic disea...
-
Anaphylaxis: guidelines from the EAACIAbstract Anaphylaxis is a clinical emergency, and all healthcare professionals should be ...
-
EAACI guideline: Preventing the development of food allergy in infants and young children (2020 update)Abstract Background: This guideline from the European Academy of Allergy and Clinical I...
-
EAACI Biologicals Guidelines - Recommendations for severe asthmaAbstract Severe asthma imposes a significant burden on patients, families and healthcare ...
-
EAACI Biologicals Guidelines - Treatment with biologicals for severe chronic rhinosinusitis with nasal polypsThe upcoming “Guidelines – treatment with biologicals for severe chronic rhinosinu...
-
EAACI Guidelines on the effective transition of adolescents and young adults with allergy and asthmaAbstract Adolescent and young adult (AYA) patients need additional support, while they ex...
-
EAACI guidelines: Anaphylaxis (2021 update)Abstract Anaphylaxis is a clinical emergency which all healthcare professionals need to b...
-
EAACI Biologicals Guidelines - dupilumab for children and adults with moderate-to-severe atopic dermatitisAbstract Atopic dermatitis imposes a significant burden on patients, families and healthc...
-
EAACI guidelines on environmental science in allergic diseases and asthma - Leveraging artificial intelligence and machine learning to develop a causality model in exposomicsThis narrative review is regarded as part of the upcoming “Guidelines on environment...
-
The international WAO/ EAACI guideline for the management of hereditary angioedema - The 2021 revision and updateAbstract Hereditary angioedema (HAE) is a rare and disabling disease for which early diag...
-
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergyAbstract Food allergy can result in considerable morbidity, impact negatively on quality ...
-
EAACI Biologicals Guidelines - Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years oldAbstract Chronic spontaneous urticaria (CSU) imposes a significant burden on patients, fa...
-
World Health Organization global air quality guideline recommendations: Executive summaryAbstract Air pollution is a leading cause of death globally and has resulted in the loss ...
-
The international EAACI/ GA²LEN/ EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticariaAbstract This update and revision of the international guideline for urticaria was develo...
Show more Guidelines (16)Show Less-
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendationsAbstract Immune modulation is a key therapeutic approach for allergic diseases, asthma an...
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforceAbstract Background Although it has been shown that allergen immunotherapy (AIT) is well-t...
-
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"Abstract Background: Although there is a considerable body of knowledge about allergen ...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract Since the introduction of allergen immunotherapy (AIT) over 100 years ago, focus...
-
Allergen immunotherapy for respiratory allergy: quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt ToolAbstract Background: Observational comparative effectiveness studies in allergen immuno...
-
The Allergen Immunotherapy Adverse Events Registry: Setup & methodology of a European Academy of Allergy and Clinical Immunology taskforce projectOver the last decades, systematic reviews and meta analyses of multiple double-blind rando...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
Role of dietary fiber in promoting immune health - An EAACI position paperAbstract Microbial metabolism of specific dietary components, such as fiber, contributes ...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paperAbstract Diagnostic allergens are defined as medicinal products in the EU. Marketing auth...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - An EAACI Task Force ReportAbstract Background: The effectiveness of allergen immunotherapy (AIT) in seasonal and ...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paperAbstract The high prevalence of allergic diseases warrants for sufficient health care pro...
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergyAbstract An accurate diagnosis of β-lactam (BL) allergy can reduce patient morbidity and...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
Food processing and occupational respiratory allergy- An EAACI position paperAbstract Occupational exposure to foods is responsible for up to 25% of cases of occupati...
-
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position PaperAbstract The immune system interacts with many nominal ‘danger’ signals, endo...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paperAbstract Allergy and respiratory disorders are common in young athletic individuals. In t...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
The urgent need for a harmonized severity scoring system for acute allergic reactionsAbstract The accurate assessment and communication of the severity of acute allergic reac...
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants - An EAACI Position PaperAbstract It is well-established that food proteins, such as egg, soya, cow’s milk a...
-
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergyAbstract The aim of this survey was to explore the specific educational needs of a cohort...
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paperAbstract A recent survey of the European Academy of Allergy and Clinical Immunology (EAAC...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statementAbstract The vision of European Academy of Allergy and Clinical Immunology (EAACI) and th...
-
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer - a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract Elevated serum IgE levels are associated with allergic disorders, parasitosis an...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest GroupAbstract Women’s work has traditionally been considered less hazardous to health in...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position PaperAbstract Background: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic...
-
ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)An ARIA-EAACI statement has been devised to make recommendations on asthma, and not necess...
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children - EAACI position paperAbstract Gastro-oesophageal reflux (GOR) and food allergy (FA) are common conditions, esp...
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentAbstract Insect venom allergy is the most frequent cause of anaphylaxis in Europe and poss...
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European surveyAbstract Background: The European Academy of Allergy and Clinical Immunology has develo...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position PaperAbstract Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT16...
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)Abstract Therapeutic advances using targeted biologicals and small-molecule drugs have ac...
-
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disordersREAD HERE
-
EAACI position paper: Comparing insect hypersensitivity induced by bite, sting, inhalation or ingestion in human beings and animalsAbstract Adverse reactions to insects occur in both human and veterinary patients. System...
-
Influenza burden, prevention, and treatment in asthma - A scoping review by the EAACI Influenza in asthma task forceAbstract To address uncertainties in the prevention and management of influenza in people...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
The development of birch pollen seasons over 30 years in Munich, Germany - An EAACI task force reportThe global warming–oriented climate change is able to induce changes in the presentation...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAbstract The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pande...
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paperAbstract Chronic airway diseases such as asthma and chronic obstructive pulmonary disease...
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperAbstract Background: Chronic rhinosinusitis is regarded as a chronic airway disease. Acc...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position PaperAbstract Multisystem inflammatory syndrome in children (MIS-C) is a rare, but severe comp...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensusAbstract Background: Although there are many asymptomatic patients, one of the problems ...
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthmaAbstract To fully understand the role of diet diversity on allergy outcomes and to set st...
-
One Health: EAACI Position Paper on coronaviruses at the human-animal interface, with a specific focus on comparative and zoonotic aspects of SARS-CoV-2Abstract The latest outbreak of a coronavirus disease in 2019 (COVID-19) caused by the se...
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paperAbstract Background: Food anaphylaxis is commonly elicited by unintentional ingestion o...
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paperAbstract Coronavirus disease 2019 (COVID-19), a respiratory tract infection caused by a n...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) - a EAACI position paperAbstract NSAID-exacerbated respiratory disease (N-ERD) is a chronic eosinophilic, inflamm...
-
Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives - A report of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract With the worldwide spread of the novel severe acute respiratory syndrome coronav...
Show more Position Papers (86)Show Less-
-
Novel approaches of allergen immunotherapy
-
How to improve compliance of allergen immunotherapy in the clinic?
-
Outcome measures for adult’s vs children in the clinic during allergen immunotherapy
-
Optimization of allergen immunotherapy care using an integrated eHealth environment
-
B cell tolerance: an essential mechanism for allergen immunotherapy in house dust mite allergy
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
Effects of combined treatment with allergen immunotherapy and dupilumab on nasal allergen challenge and tolerability of immunotherapy
-
Allergen immunotherapy for food allergy
-
Allergen immunotherapy: nasal allergen vs chamber challenges vs other tests
-
Allergen immunotherapy has a role in the era of biologics (Con&Pro Session: Con)
-
Placebo effects in Allergen Immunotherapy: guidelines and regulatory recommendations
-
